Filters
Term Search
You can select from the dropdown list OR enter your own terms to refine the search.
Last Updated: 10/31/2025
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 119 publications
Solid phase extraction and high-performance liquid chromatographic determination of lazertinib in human plasma.
Journal: Drug discoveries & therapeutics
Published: October 19, 2025
Overall Survival with Amivantamab-Lazertinib in EGFR-Mutated Advanced NSCLC.
Journal: The New England journal of medicine
Published: September 09, 2025
Cardiovascular adverse events associated with epidermal growth factor receptor tyrosine kinase inhibitors in EGFR-mutated non-small cell lung cancer: systematic review and network meta-analysis.
Journal: BMJ (Clinical research ed.)
Published: September 02, 2025
A Response to the Letter to the Editor Regarding "Lazertinib for Patients With NSCLC Harboring Uncommon EGFR Mutations".
Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Published: July 22, 2025
Comprehensive management strategies for amivantamab-induced toxicities and review of the literature.
Comprehensive management strategies for amivantamab-induced toxicities and review of the literature.
Journal: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners
Published: July 15, 2025
Clinical Pharmacokinetic Assessment of Lazertinib in Healthy Adult Participants: Effects of GSTM1 Genotype.
Journal: Clinical drug investigation
Published: June 27, 2025
Enhanced Versus Standard Dermatologic Management With Amivantamab-Lazertinib in EGFR-Mutated Advanced NSCLC: The COCOON Global Randomized Controlled Trial.
Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Published: June 17, 2025
Dermatologic Adverse Event Mitigation and Management Strategies with Amivantamab + Lazertinib Therapy for Advanced Non-Small Cell Lung Cancer: A Vodcast.
Journal: Targeted oncology
Published: June 14, 2025
Recent Advances in the Management of EGFR-Mutated Advanced Non-Small Cell Lung Cancer-A Narrative Review.
Journal: Current oncology (Toronto, Ont.)
Published: June 13, 2025
Central Nervous System Outcomes of Lazertinib Treatment in EGFR-Mutated Advanced NSCLC: Pooled Analysis From LASER201 and LASER301.
Journal: Clinical lung cancer
Published: May 30, 2025
Navigating First-Line Treatment Options for Patients With Epidermal Growth Factor Receptor-Positive Non-Small Cell Lung Cancer.
Journal: American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting
Published: May 30, 2025
Last Updated: 10/31/2025